NextCure (NXTC) Change in Acquisitions & Divestments (2020 - 2026)

NextCure's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 93.83% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $32.5 million (down 66.23% YoY), while the FY2025 annual figure was $52.3 million, down 49.86% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $1.3 million, down from $6.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $49.8 million in Q1 2023, with the low at $1.3 million in Q1 2026.
• The 5-year median for Change in Acquisitions & Divestments is $21.1 million (2025), against an average of $22.1 million.
• The sharpest annual moves came in 2023 and 2026: Change in Acquisitions & Divestments jumped 255.34% in 2023, then slumped 93.83% in 2026.
• NextCure's Change in Acquisitions & Divestments stood at $26.7 million in 2022, then tumbled by 40.13% to $16.0 million in 2023, then slipped by 4.56% to $15.3 million in 2024, then tumbled by 60.67% to $6.0 million in 2025, then tumbled by 78.34% to $1.3 million in 2026.
• Business Quant data shows NXTC's Change in Acquisitions & Divestments at $1.3 million in Q1 2026, $6.0 million in Q4 2025, and $8.7 million in Q3 2025.